LLY Jan 2025 175.000 call
| Previous Close | 183.10 |
| Open | 183.10 |
| Bid | 161.50 |
| Ask | 165.50 |
| Strike | 175.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 183.10 - 183.10 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 30 |
ZacksACM Research and Advance Auto Parts have been highlighted as Zacks Bull and Bear of the Day
ACM Research and Advance Auto Parts have been highlighted as Zacks Bull and Bear of the Day.
ReutersUPDATE 3-U.S. FDA declines to approve Eli Lilly's drug to treat eczema
The U.S. Food and Drug Administration (FDA) has declined to approve Eli Lilly's drug to treat a type of skin disease due to certain findings during an inspection of a contract manufacturer, the drugmaker said on Monday. The company said the agency did not raise concerns about the clinical trial data, safety or label for lebrikizumab, a monoclonal antibody for treatment of atopic dermatitis, or eczema.
BloombergUpstart Weight-Loss Drugmaker Jumps 75% on Strong Test Results
(Bloomberg) -- Structure Therapeutics Inc. jumped to a record high Friday after new data on its oral weight-loss drug fueled expectations that the San Francisco-based company is closing the gap with larger competitors such as Pfizer Inc.Most Read from BloombergEurope’s Richest Royal Family Builds $300 Billion Finance EmpirePakistan Rupee Set to Become Top Performing Currency Globally Top Chinese Scientist Claims India Moon Landing Nowhere Near South PoleStock Optimism Fizzles as Quarterly Losses
